Sign up for Table of Contents Alerts.
Email this page
Print this page
Commentary
Progress towards the use of HIV proteases in cancer therapy
Eric J. Bernhard and Thomas B. Brunner
volume 7 | issue 5
May 2008Pages: 636 - 637
Subscribe to this journal for $129/year
Commentary to:
Validation and Toxicity of PI3K/Akt Pathway Inhibition by HIV Protease Inhibitors in Humans
John P. Plastaras, Neha Vapiwala, Mona S. Ahmed, Deborah Gudonis, George J. Cerniglia, Michael D. Feldman, Ian Frank, Anjali K. Gupta